Acceptance and Commitment Therapy for individuals at risk for psychosis or with a first psychotic episode: A qualitative study on patients’ perspectives
Bouws, J., Henrard, A.,
De Koning, M.B.,
Schirmbeck, F., van Ghesel Grothe, S., van Aubel, E., Reininghaus, U.,
De Haan, L. & Myin-Germeys, I.
Verschenen in Early Intervention in Psychiatry, 1-10 (2023)
Patients’ and volunteer coaches’ experiences with an informal social network intervention in forensic psychiatric care: a qualitative analysis
Swinkels, L.T.A.,
De Koning, M.B.,
Van der Pol, T.M.,
Dekker, J.J.M.,
Ter Harmsel, J.F. &
Popma, A.Verschenen in BMC Psychiatry, 23 (2023)
Diversiteit en psychiatrie
De Koning, M.B., Dom, G., Duvivier, R.,
Muller, D.P., Özgen, M.H., Rhebergen, D. &
Van, H.Verschenen in Tijdschrift voor psychiatrie , 64, 485-486 (2022)
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorder
Okhuijsen-Pfeifer, C., van der Horst, M.Z., Bousman, C.A., Lin, B., van Eijk, K.R., Ripke, S., Ayhan, Y., Jeger-Land, E.,
De Koning, M.B., GROUP investigators & Luykx, J. (et al.)
Verschenen in Translational Psychiatry, 12, 145 (2022)
De ondervertegenwoordiging van complexe patiëntengroepen in wetenschappelijk onderzoek: ethische overwegingen
De Koning, M.B.,
Burger, T.,
Van Eck, R.,
Kikkert, M.J.,
De Haan, L. &
Vellinga, A.Verschenen in Tijdschrift voor Psychiatrie, 63, 731-736 (2021)
Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach
de Nijs, J.,
Burger, T., Janssen, R.J., Mostafa Kia, S., van Opstal, D.P.J.,
De Koning, M.B.,
De Haan, L., GROUP Investigators, Cahn, W. & Schnack, H.G.
Verschenen in Nature: Schizophrenia (2021)
Medication strategies in first episode psychosis patients: A survey among psychiatrists
Kikkert, M.J., Veling, W.,
De Haan, L., Begemann, M.J.H.,
De Koning, M.B., HAMLETT and OPHELIA Consortium & Sommer, I.E.
Verschenen in Early Intervention in Psychiatry, 1-8 (2021)
Beeldbellen in de GGZ: de mening van cliënten van Arkin
De Beurs, E.,
Blankers, M.,
Goudriaan, A.E.,
De Koning, M.B. &
Dekker, J.J.M.Verschenen in Tijdschrift voor Psychotherapie, 47, 176-184 (2021)
Zorgverlening in tijden van corona: ervaringen van behandelaars met zorg-op-afstand
De Beurs, E.,
Blankers, M.,
Goudriaan, A.E.,
De Koning, M.B. &
Dekker, J.J.M.Verschenen in Tijdschrift Voor Psychiatrie, 63 (4), 242-249 (2021)
Association between cognitive phenotype in unaffected siblings and prospective 3- and 6-year clinical outcome in their proband affected by psychosis
Burger, T.,
Schirmbeck, F., Vermeulen, J.M., Quee, P.J.,
De Koning, M.B., Bruggeman, R. &
De Haan, L.Verschenen in Psychological Medicine, 1-11 (2020)
The bumpy road to achieve reliability of clinical profile characteristics in psychosis and related disorders
Berendsen, S., van Tricht, M.J., Tedja, A.,
Burger, T.,
De Koning, M.B. &
De Haan, L.Verschenen in International Journal of Methods in Psychiatric Research, Volume 30, Issue 2, 1-8 (2020)
The impact of affective symptoms on personal recovery of patients with severe mental illness
Van Eck, R.,
Burger, T., Schenkelaars, M.,
Vellinga, A.,
De Koning, M.B.,
Schirmbeck, F.,
Kikkert, M.J.,
Dekker, J.J.M. &
De Haan, L.Verschenen in International Journal of Social Psychiatry , Vol. 64 (6), 521-527 (2018)
Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis
Vingerhoets, C., Bloemen, O.J.N., Boot, E., Bakker, G.,
De Koning, M.B., da Silva Alves, F., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Psychiatrie Research: Neuroimaging, 272, 65-70 (2018)
Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis
Bakker, G., Caan, M.W.A., Schluter, R.S., Bloemen, O.J.N., da Silva-Alves, F.,
De Koning, M.B., Boot, E., Vingerhoets, W.A.M., Nieman, D.H.,
De Haan, L., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Psychological Medicine, 46 (11) (2016)
Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome
Bakker, G., Caan, M.W.A., Vingerhoets, W.A.M., da Silva-Alves, F.,
De Koning, M.B., Boot, E., Nieman, D.H.,
De Haan, L., Bloemen, O.J., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in PlosOne (2016)
Homesick: residential and care patterns in patients with severe mental illness
De Mooij, L.D.,
Kikkert, M.J.,
Lommerse, N.M., Theunissen, J.,
De Koning, M.B.,
De Haan, L.,
Beekman, A.T.F.,
Duurkoop, P.W.R.A. &
Dekker, J.J.M.Verschenen in BMC Psychiatry, 16, 431 (2016)
Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.
Evers, L.J., van Amelsvoort, T.A., Bakker, J.A.,
De Koning, M.B., Drukker, M. & Curfs, L.M.
Verschenen in Psychopharmacology (Berl), 232 (18), 3319-3325 (2015)
